BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kabbara WK, Sarkis AT, Saroufim PG. Acute and Fatal Isoniazid-Induced Hepatotoxicity: A Case Report and Review of the Literature. Case Rep Infect Dis 2016;2016:3617408. [PMID: 27648319 DOI: 10.1155/2016/3617408] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Almeida MS, Gomes F, Ginga MDR, Fernandes M, Cartucho J. Isoniazid-Induced Acute Liver Failure Requiring Liver Transplantation. Cureus 2022;14:e32905. [PMID: 36699772 DOI: 10.7759/cureus.32905] [Reference Citation Analysis]
2 Selvaraj H, Dhamothrasamy K, Duraisamy K, Dhanasekaran M. Isoniazid-induced hepatic injury: a case report and its mechanism of liver injury. J Adv Pharm Educ Res 2022;12:1-5. [DOI: 10.51847/hjao9qjb8t] [Reference Citation Analysis]
3 Zhong T, Fan Y, Dong XL, Guo X, Wong KH, Wong WT, He D, Liu S. An Investigation of the Risk Factors Associated With Anti-Tuberculosis Drug-Induced Liver Injury or Abnormal Liver Functioning in 757 Patients With Pulmonary Tuberculosis. Front Pharmacol 2021;12:708522. [PMID: 34819852 DOI: 10.3389/fphar.2021.708522] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
4 Kleinwaks G, Schmit V, Morrison J. Considering human challenge trials for tuberculosis vaccine development. Vaccine 2021:S0264-410X(21)01469-9. [PMID: 34922788 DOI: 10.1016/j.vaccine.2021.11.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hannah A, Dick M. Identifying gaps in the quality of latent tuberculosis infection care. J Clin Tuberc Other Mycobact Dis 2020;18:100142. [PMID: 31956699 DOI: 10.1016/j.jctube.2020.100142] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
6 Russom M, Debesai M, Zeregabr M, Berhane A, Tekeste T, Teklesenbet T. Serious hepatotoxicity following use of isoniazid preventive therapy in HIV patients in Eritrea. Pharmacol Res Perspect 2018;6:e00423. [PMID: 30073087 DOI: 10.1002/prp2.423] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
7 Jaladanki CK, Shaikh A, Bharatam PV. Biotransformation of Isoniazid by Cytochromes P450: Analyzing the Molecular Mechanism using Density Functional Theory. Chem Res Toxicol 2017;30:2060-73. [DOI: 10.1021/acs.chemrestox.7b00129] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]